{"grounding": "Parkinson's disease (PD) is clinically, pathologically, and genetically heterogeneous, resisting distillation to a single, cohesive disorder. Instead, each affected individual develops a virtually unique form of Parkinson's syndrome. Clinical manifestations consist of variable motor and nonmotor features, and myriad overlaps are recognized with other neurodegenerative conditions. Although most commonly characterized by alpha-synuclein protein pathology throughout the central and peripheral nervous systems, the distribution varies and other pathologies commonly modify PD or trigger similar manifestations. Nearly all PD is genetically influenced. More than 100 genes or genetic loci have been identified, and most cases likely arise from interactions among many common and rare genetic variants. Despite its complex architecture, insights from experimental genetic dissection coalesce to reveal unifying biological themes, including synaptic, lysosomal, mitochondrial, andimmune-mediated mechanisms of pathogenesis. This emerging understanding of Parkinson's syndrome, coupled with advances in biomarkers and targeted therapies, presages successful precision medicine strategies.", "generated_text": "Parkinson's syndrome, encompassing Parkinson's disease and related parkinsonism disorders, is a complex neurodegenerative condition with diverse genetic and environmental factors contributing to its pathogenesis. This review explores the genetic landscape of Parkinson's syndrome, highlighting the roles of key genes such as GBA, LRRK2, and alpha-synuclein. We discuss the emerging concept of oligogenic inheritance and the application of functional genomics in unraveling disease mechanisms. The heterogeneity of Parkinson's syndrome is examined, emphasizing the interplay between genetic variants and cellular processes. Particular attention is given to the involvement of synaptic dysfunction, lysosomal impairment, and mitochondrial abnormalities in disease progression. By integrating recent genetic discoveries with cellular and molecular insights, this review provides a comprehensive understanding of Parkinson's syndrome pathogenesis, paving the way for novel therapeutic strategies and personalized medicine approaches.", "label": 1}